Built From Deals That Raised Real Funding: CAR‑T Therapy Pitch Deck Template

You’re working at the cutting edge of immunotherapy: CAR‑T cells, engineered precision, life‑changing potential. But when you pitch to investors, something’s missing. The science is strong; the vision is clear — yet the funding doesn’t show.

Here’s the deal: it’s not just about the therapy—it’s about how you present it. This template isn’t generic. It’s built on pitch decks that have already helped raise real funds for CAR‑T and similar biotech platforms. Slide by slide, it guides you through the problem (unmet need), your solution (CAR‑T innovation), the market opportunity, clinical validation, regulatory approach, business model, team, and the ask—in a flow that investors recognize and respond to.

Sup. I’m Viktor, a presentation expert, consultant, and burger lover. For the past 13 years I’ve helped clients raise millions, and win deals, funding and campaigns, with my unique approach to developing presentations. I’m sharing that approach in this virtual reality pitch deck guide.

If you’re raising capital for a CAR‑T therapy platform, cell therapy pipeline, or next‑gen immunotherapy, this gives you the structure, clarity, and credibility to pitch like you mean business.

Fresh Case Study: Check out how we helped Harmon build a pitch deck for their hormonal therapy platform, and how Scarcell Therapeutics got an investor ready pitch deck for their cell therapy treatment method.

Get My 12 Slide Framework That Got $500mil in Funding For Clients.

What do you think of having 12 dead simple formulas, that will help you craft 12 slides, in about 1 hour? That’s what you’ll get, when you download my 12 slide framework. Save hours crafting your pitch deck copy with my tested approach that includes:

Elevator pitch one sentence formula
Problem/ solution slide one sentence formula
Competitor slide one sentence formula
9 other formulas, tips, tricks and advice

The formulas worked for 40+ industries and 500+ companies. Including the one you’re looking at now.

Get it On Gumroad

Get It On Patreon

Clicking the link won’t charge you anything.

“The amount of know-how Viktor has about the industry is astounding. No wonder he can build a pitch deck for just about any product or service; completely hands-off.”

★★★★★

Your 13 Slide CAR-T Therapy Pitch Deck Template: Transforming Data Into Dollars, One T-Cell at a Time | Google Slides

The above is is just a simplified template.

Founders that are serious about getting the funding they need, opt in for a deck has industry specific content, superb narrative and award winning design like these ones below:

I can help you build that deck with my hands-off process in 7 days or less.

Book a free 30 minute call below if you’re serious about getting an investor ready deck, and we’ll discuss your needs in detail. I’ll help you design the deck, write the content, develop the narrative and flesh out the strategy with financials.

Book the free call

★★★★★

Slide 1: Introduction

Title: Revolutionizing Healthcare: The Future of Cell & Gene Therapy with CAR-T

Company Logo
Mission Statement: “At [Company Name], we are dedicated to transforming healthcare through innovative cell and gene therapies, with a primary focus on advancing CAR-T therapy to revolutionize the treatment of cancer and other diseases.”
Key Points:
- Brief overview of the company’s founding year and location.
- Highlight any significant achievements or milestones.
- Emphasize the commitment to pioneering advancements in cell and gene therapy.

Slide 2: Market Opportunity

Title: Unlocking the Potential of Cell & Gene Therapy

Market Overview:
- The global cell and gene therapy market is projected to reach [insert market size] by [insert year], growing at a CAGR of [insert percentage].
- Specific focus on the CAR-T therapy segment, which is anticipated to witness robust growth due to its potential in treating various cancers and other diseases.
CAR-T Therapy Market:
- CAR-T therapy is a rapidly expanding segment within the broader cell and gene therapy market.
- Highlight key statistics and forecasts demonstrating the growth potential of CAR-T therapy.
- Emphasize the increasing adoption of CAR-T therapy by healthcare providers and patients globally.
Key Trends:
- Discuss significant trends driving the growth of the cell and gene therapy market, such as advancements in technology, increasing investment, and evolving regulatory landscapes.
- Highlight how these trends create a favorable environment for innovation and market expansion in the CAR-T therapy space.

Slide 3: Problem Statement

Title: Addressing Unmet Medical Needs

Current Limitations:
- Traditional treatments for diseases like cancer often have limited efficacy and can cause significant side effects.
- Highlight specific challenges such as disease relapse, treatment resistance, and lack of durable responses.
Unmet Medical Needs:
- Discuss the critical unmet medical needs in current treatment paradigms, emphasizing the need for more effective and targeted therapies.
- Provide examples of patient populations that have limited treatment options and could benefit from advancements in CAR-T therapy.
Opportunity for Innovation:
- Position CAR-T therapy as a transformative approach that has the potential to address the shortcomings of traditional treatments.
- Highlight the opportunity for innovation in developing more precise, personalized, and durable therapies through CAR-T technology.

Slide 4: Solution

Title: Transforming Treatment with CAR-T Therapy

Introduction to CAR-T Therapy:
- Provide a concise overview of CAR-T therapy, explaining its mechanism of action and how it harnesses the power of the immune system to target cancer cells.
- Use visuals or diagrams to illustrate the process of CAR-T cell therapy, making it easily understandable for a non-technical audience.
Advantages of CAR-T Therapy:
- Highlight the key advantages of CAR-T therapy over traditional treatments, such as higher response rates, lower toxicity, and potential for long-term remission.
- Showcase compelling data from clinical trials demonstrating the efficacy and safety of CAR-T therapy in various cancer types.
Potential Applications:
- Discuss the broad potential applications of CAR-T therapy beyond cancer, such as treating autoimmune diseases and genetic disorders.
- Highlight the versatility of CAR-T technology and its ability to target different antigens and disease pathways.

Hold on. You might want to check my list on the best presentation and communication books...

These are crucial books that will help you improve the design and structure of your decks and presentations, besides improving your delivery and skyrocketing your confidence when facing investors. Check them out below.

10 Best Presentation Books

26 Best Communication Books

Slide 5: Technology and Intellectual Property

Title: Innovating with Proprietary Technologies

Technology Overview:
- Provide an overview of the proprietary technologies and platforms developed by the company to advance CAR-T therapy.
- Highlight any unique features or innovations that differentiate the company’s approach from competitors.
Intellectual Property Portfolio:
- Discuss the company’s intellectual property portfolio, including patents, licenses, and other proprietary assets.
- Emphasize the strength and breadth of the company’s IP position in the field of cell and gene therapy, particularly in CAR-T technology.
Competitive Advantage:
- Position the company’s technology and IP portfolio as a significant competitive advantage, enabling the development of novel and differentiated CAR-T therapies.
- Showcase examples of how the company’s technology platform enables the rapid and cost-effective development of new therapies.

Slide 6: Product Pipeline

Title: Advancing Breakthrough Therapies

Pipeline Overview:
- Provide a visual representation of the company’s product pipeline, highlighting lead CAR-T therapy candidates and their targeted indications.
- Briefly describe each product candidate, including its stage of development and therapeutic potential.
Milestones Achieved:
- Showcase key milestones achieved in the development of the company’s CAR-T therapy candidates, such as successful preclinical studies, regulatory approvals, or clinical trial advancements.
- Emphasize any significant data readouts or regulatory milestones reached to date.
Upcoming Milestones:
- Outline the company’s upcoming milestones, including planned clinical trial initiations, data readouts, and regulatory submissions.
- Highlight the potential value inflection points that these milestones represent for investors and stakeholders.

Slide 7: Market Strategy

Title: Driving Commercial Success

Target Patient Populations:
- Identify the target patient populations for the company’s CAR-T therapy candidates, focusing on specific cancer types or disease indications with high unmet medical needs.
- Discuss the prevalence and epidemiology of these diseases to underscore the market opportunity.
Healthcare Providers:
- Outline the company’s strategy for engaging and partnering with healthcare providers, including hospitals, clinics, and academic medical centers.
- Highlight efforts to educate healthcare professionals about the benefits of CAR-T therapy and facilitate patient referrals.
Distribution and Commercialization:
- Describe the company’s plans for commercializing its CAR-T therapies, including distribution channels, sales force deployment, and marketing strategies.
- Discuss market access strategies, reimbursement considerations, and pricing models to ensure broad patient access.

Slide 8: Competitive Landscape

Title: Positioning for Success in a Dynamic Market

Competitor Analysis:
- Provide an overview of key competitors in the CAR-T therapy space, including both established pharmaceutical companies and emerging biotech firms.
- Highlight their respective CAR-T therapy programs, pipeline candidates, and competitive strengths.
Differentiation Factors:
- Articulate the unique selling points and competitive advantages of the company’s CAR-T therapy platform compared to competitors.
- Highlight factors such as superior efficacy, safety profile, target antigen selection, or manufacturing scalability.
Market Positioning:
- Discuss the company’s positioning within the competitive landscape, emphasizing its ability to capture market share and establish leadership in specific disease areas or patient populations.
- Illustrate how the company’s strategic advantages translate into sustainable competitive differentiation and long-term value creation.

Slide 9: Regulatory and Clinical Pathway

Title: Navigating the Path to Approval

Regulatory Landscape:
- Provide an overview of the regulatory framework governing the development and approval of cell and gene therapies, including CAR-T.
- Discuss key regulatory agencies, pathways (e.g., FDA’s RMAT designation), and requirements for market authorization.
Regulatory Strategy:
- Outline the company’s regulatory strategy for advancing its CAR-T therapy candidates through the development and approval process.
- Highlight interactions with regulatory authorities, ongoing discussions, and any special considerations for expedited pathways or orphan drug designations.
Clinical Development Plans:
- Detail the company’s clinical development plans, including ongoing and planned clinical trials for its CAR-T therapy candidates.
- Discuss trial designs, patient recruitment strategies, and endpoints to support regulatory approval and market differentiation.

Slide 10: Financial Projections

Title: Building Value through Strategic Growth

Revenue Projections:
- Present financial projections for the company, including revenue forecasts based on market opportunity, pricing assumptions, and anticipated adoption rates.
- Discuss potential revenue drivers, such as product sales, licensing agreements, or strategic partnerships.
Cost Structure:
- Break down the company’s cost structure, including R&D expenses, manufacturing costs, commercialization expenses, and general overhead.
- Discuss strategies for managing costs and optimizing resource allocation to maximize return on investment.
Funding Needs:
- Highlight the company’s funding history, including previous investment rounds, grants, and partnerships.
- Outline future funding needs and financing strategies, including potential sources of capital (e.g., venture funding, strategic partnerships, public offerings) to support ongoing operations and growth initiatives.

Slide 11: Team

Title: Expertise Driving Innovation

Executive Team:
- Introduce key members of the executive team, including the CEO, CFO, CTO, and other C-suite executives.
- Highlight their relevant experience, expertise, and track record in the biotechnology industry, particularly in the field of cell and gene therapy.
Scientific Advisory Board:
- Highlight the company’s scientific advisory board (SAB) members, comprising renowned experts in oncology, immunology, and molecular biology.
- Discuss the role of the SAB in guiding the company’s research and development efforts and ensuring scientific rigor and innovation.
Operational Team:
- Showcase the broader team responsible for executing the company’s strategic objectives, including research scientists, clinical development specialists, regulatory affairs professionals, and commercialization experts.
- Emphasize the depth and breadth of talent within the organization and its collective commitment to advancing the company’s mission.

Slide 12: Conclusion

Title: Partnering for a Healthier Future

Recap of Mission:
- Summarize the company’s mission and vision for transforming healthcare through innovative cell and gene therapies, with a focus on CAR-T therapy.
- Reinforce the commitment to addressing unmet medical needs and improving patient outcomes.
Key Takeaways:
- Recap the key highlights and value propositions presented throughout the pitch deck, emphasizing the company’s unique strengths, competitive advantages, and growth potential.
- Encourage stakeholders to consider the compelling investment opportunity and potential impact of supporting the company’s mission.
Next Steps:
- Invite investors, partners, and stakeholders to further engage with the company, whether through follow-up meetings, due diligence inquiries, or partnership discussions.
- Provide contact information for key representatives and offer assistance in scheduling additional meetings or providing additional information as needed.

Slide 13: Appendix

Title: Additional Resources

Data and Charts:
- Include additional data, charts, and graphs supporting key points presented throughout the pitch deck.
- Provide detailed clinical trial results, market research findings, or financial projections to further bolster the company’s value proposition.
References and Citations:
- Include references and citations for any data, studies, or external sources referenced in the pitch deck.
- Ensure transparency and credibility by providing sources for all information presented.
Legal Disclaimers:
- Include any necessary legal disclaimers or disclosures related to forward-looking statements, regulatory considerations, or investment risks.
- Ensure compliance with applicable regulations and standards to mitigate any potential legal or regulatory risks.

Pick a specific pitch deck design from the award winning Envato.

1000’s of ready made Powerpoint, Google Slides, and Keynote presentations that are easy to edit, format and tailor to your idea.

Grab The Deal And Build Your Deck

Last Words

You now hold a 13‑slide blueprint designed for CAR‑T therapy ventures—one grounded in decks that already raised real capital.

If this aligns with your project, adapt it, refine it, and pitch with confidence. If your technology, regulatory path, or business model has unique elements—reach out. I’ll help you tailor the deck so it fits your vision, strengthens your narrative, and maximizes your chances of funding.

Get an investor ready pitch deck that gets you funded and saves over 30 hours of your time.

Join 100s of successful entrepreneurs who’ve transformed their pitch decks by using my hands-off approach, which includes: market research, copy, design, financials, narrative and strategy.

1 week turnaround time and less. Special pricing for early stage companies.

Start Winning Investors. Book The Free Exploratory Call.

The least you will get on this call is 10 actionable tips & strategies to own that next pitch, worth $599, for free.